Odyssey Health (ODYY) Other Non-Current Liabilities (2019 - 2026)
Odyssey Health (ODYY) posted quarterly Other Non-Current Liabilities of $2.4 million for Q2 2026, down 38.25% quarter-over-quarter from $3.9 million in Q1 2026.
Odyssey Health (ODYY) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Odyssey Health's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $2.4 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities changed N/A year-over-year to $2.4 million; the TTM figure through Apr 2026 stood at $2.4 million (changed N/A YoY), while the FY2019 annual figure was $144000.0, changed N/A from the prior year.
- Other Non-Current Liabilities for Q2 2026 stood at $2.4 million, down from $3.9 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $3.9 million in Q1 2026, with the low at $225155.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.43 Mn |
| Jan 31, 2026 | 3.94 Mn |
| Oct 31, 2025 | 225,155.00 |
| Apr 30, 2020 | 144,000.00 |
| Jan 31, 2020 | 144,000.00 |
| Oct 31, 2019 | 144,000.00 |
| Jul 31, 2019 | 144,000.00 |